Free Trial

Arcellx (ACLX) Stock Forecast & Price Target

$53.81
+0.06 (+0.11%)
(As of 06/18/2024 ET)

Arcellx - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$78.00
44.95% Upside
High Forecast$87.00
Average Forecast$78.00
Low Forecast$52.00
TypeCurrent Forecast
6/20/23 to 6/19/24
1 Month Ago
5/21/23 to 5/20/24
3 Months Ago
3/22/23 to 3/21/24
1 Year Ago
6/20/22 to 6/20/23
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
12 Buy rating(s)
13 Buy rating(s)
10 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$78.00$78.73$69.14$51.58
Forecasted Upside44.95% Upside33.94% Upside17.10% Upside50.41% Upside
Get Arcellx Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ACLX and its competitors with MarketBeat's FREE daily newsletter.

ACLX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ACLX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Arcellx Stock vs. The Competition

TypeArcellxMedical CompaniesS&P 500
Consensus Rating Score
3.07
2.70
2.50
Consensus RatingBuyModerate BuyHold
Predicted Upside44.95% Upside1,068.18% Upside11.31% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/18/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$87.00 ➝ $87.00+61.62%
5/31/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Amin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$70.00+34.00%
5/15/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$82.00 ➝ $83.00+63.97%
5/14/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$85.00+70.79%
5/13/2024HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$82.00 ➝ $80.00+64.20%
5/7/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$81.00+53.79%
4/4/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform$82.00+29.75%
3/7/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$81.00+11.03%
2/29/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$66.00 ➝ $85.00+28.55%
2/29/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$62.00 ➝ $73.00+8.44%
2/29/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$63.00 ➝ $77.00+14.38%
10/30/2023TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform
10/17/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$52.00+52.67%
10/12/2023Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Graybosch
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
5/10/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$39.00 ➝ $50.00+10.52%
4/24/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$45.00 ➝ $58.00+45.22%
3/30/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$35.00 ➝ $39.00+27.74%
3/30/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$35.00 ➝ $39.00+25.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:01 AM ET.

ACLX Forecast - Frequently Asked Questions

What is Arcellx's stock forecast and purchase recommendation?

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Arcellx is $78.00, with a high forecast of $87.00 and a low forecast of $52.00. The consensus rating for Arcellx stock is Buy based on the current 13 buy ratings and 1 strong buy rating for ACLX. Learn more on ACLX's analyst rating history.

Do Wall Street analysts like Arcellx more than its competitors?

Analysts like Arcellx more than other "medical" companies. The consensus rating for Arcellx is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ACLX compares to other companies.

Is Arcellx being upgraded by Wall Street analysts?

Over the previous 90 days, Arcellx's stock had 1 upgrade by analysts.

Does Arcellx's stock price have much upside?

According to analysts, Arcellx's stock has a predicted upside of 37.17% based on their 12-month stock forecasts.

What analysts cover Arcellx?

Arcellx has been rated by research analysts at Evercore ISI, HC Wainwright, Needham & Company LLC, Piper Sandler, Scotiabank, Stifel Nicolaus, and Truist Financial in the past 90 days.


Stock Forecasts and Research Tools

This page (NASDAQ:ACLX) was last updated on 6/19/2024 by MarketBeat.com Staff

From Our Partners